FOXJ1, a novel oncosupressor transcription factor in a subgroup of PDAC patients
Pancreatic ductal adenocarcinoma (PDAC) is one of the most prevalent and deadliest cancers. It is predicted to become the second leading cause of cancer mortality within a decade, with an overall 5-year survival of 9%. The existing literature extensively supports the notion that epigenetic modifications and alterations...